Prevention and treatment of acute GvHD


GvHD remains a source of significant morbidity and mortality in the setting of allogeneic haematopoietic SCT. Improving outcomes in stem cell transplant recipients requires additional therapeutic modalities for GvHD, especially for patients who fail to respond to initial therapy with steroids. Moreover, while the absence of acute GvHD (aGvHD) is associated… (More)
DOI: 10.1038/bmt.2008.57


1 Figure or Table

Slides referencing similar topics